This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Agathosma crenulata
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
The oval-leaf buchu species used alongside round-leaf buchu for urinary tract conditions.
The oval-leaf buchu species used alongside round-leaf buchu for urinary tract conditions. Key active compounds include diosphenol, pulegone, flavonoids.
diosphenol, along with pulegone and flavonoids, are the primary bioactive compounds in Agathosma crenulata. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth.
Urinary antimicrobial use
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Diuretic activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory research
Urinary tract conditions
Based on traditional use; clinical evidence limited
Diuretic herb
Based on traditional use; clinical evidence limited
Kidney support
Based on traditional use; clinical evidence limited
Found an error or have a correction for Agathosma crenulata?
Report an Issue →